Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Class A Common Stock, par value $0.0001 per share
-
Shares outstanding
-
40,568,426
-
Total 13F shares
-
19,599,540
-
Share change
-
-764,500
-
Total reported value
-
$792,990,412
-
Put/Call ratio
-
49%
-
Price per share
-
$40.46
-
Number of holders
-
215
-
Value change
-
-$21,506,319
-
Number of buys
-
116
-
Number of sells
-
102
Institutional Holders of PHIBRO ANIMAL HEALTH CORP - Class A Common Stock, par value $0.0001 per share (PAHC) as of Q3 2025
As of 30 Sep 2025,
PHIBRO ANIMAL HEALTH CORP - Class A Common Stock, par value $0.0001 per share (PAHC) was held by
215 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,599,540 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, STATE STREET CORP, ACADIAN ASSET MANAGEMENT LLC, FMR LLC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, DIMENSIONAL FUND ADVISORS LP, Nuveen, LLC, and MORGAN STANLEY.
This page lists
215
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.